OptiBiotix* (OPTI): LP-LDL agreement for US and ROW (CORP) | Proactis* (PHD): Strong trading update (CORP)
22 Aug 2017
Morning Note
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
Morning Note
- Published:
22 Aug 2017 -
Author:
Andrew Darley | Mark Brewer | Cavendish Research -
Pages:
4 -
OptiBiotix* (OPTI): LP-LDL agreement for US and ROW (CORP) | Proactis* (PHD): Strong trading update (CORP)